LEUCINE RICH BIO PVT. LTD.

Company Overview

Founded in 2014, Leucine Rich Bio provides bioinformatic and consulting services, as well as genetic testing services to India’s market. Leucine offers Advanced Genome Interpretation Ste. (AGIS) to report disease-causing mutations. The company’s LRB-Vries (Variation Repositories) is a repository of human genetic variations, along with validation data.

In February 2017, Leucine Rich Bio formed a partnership with Pytheos Health Systems that offers wellness and fitness services to athletes, fitness professionals and wellness users. This alliance gave Leucine Rich Bio access to a specialized fitness market segment and two web portals: MyDiagnostics (discovery diagnostics and assessments) and HumanFractal.io (goal-driven and personal-
based programs).

The clinical NGS software-as-a-service (SaaS) market is composed of companies that license NGS analysis and interpretation software on a subscription basis and is centrally hosted. Key companies include Leucine Rich Bio, Strand (StrandOmics interpretation software), Tute Genomics (cloud-based interpretation based on AnnoVar software), iBionom (clinical genome interpretation software), Diploid (variant interpretation services), Gentle (variant interpretation services) and Codified Genomics (tools for interpretation of genome-wide sequencing data).

Leucine Rich Bio’s platform (AGIS) is used for diagnosing genetic and Mendelian disorders. The platform provides reports on the causative genetic variants by using a proprietary ranking algorithm. The results are given by ACMG guidelines for reporting sequencing variants ranging from Category 1 (i.e., previously reported variants recognized as pathogenic) through Category 4 (i.e., previously reported variants unlikely to be disease causing).

Company's Business Segments

• Genomics-based Platform : The company provides genomic data-based solutions in the oncology domain.